AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 301 min read$KVUE

Kenvue: Q3 Earnings Snapshot

Kenvue Inc. (KVUE) reported Q3 profit of $430M, or 22 cents per share, beating analyst estimates of 28 cents per share. Adjusted earnings were 29 cents per share. Revenue was $3.89B, matching forecasts.

Original reporting
finance.yahoo.com
Published Oct 30, 2026, 10:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 10:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Kenvue: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$KVUEBullishMed
01

Why it matters

The earnings beat provides a fresh catalyst that could drive short‑term price appreciation.

02

Market read

First‑report earnings with a beat; material for traders looking for short‑term moves.

03

What to watch

Potential cost pressures from restructuring could temper long‑term momentum.

Relevance 8/10Novelty 8/10Timing: after-hours Friday release

Background

Kenvue is the consumer‑health spinoff of Johnson & Johnson, listed on NYSE under KVUE.

Company-level read

Ticker impact

$KVUEBullishHigh confidence
Context

Kenvue reported Q3 profit of $430M, EPS 22¢ (adjusted 29¢) beating estimates and revenue $3.89B.

Expected impact

upward pressure as market prices in the earnings beat

Evidence & confidence

The beat of both earnings per share and revenue expectations provides fresh, material information that can move the share price.

Market effects

Sector

Consumer health sector may see modest uplift from a large peer's beat.

Regional

U.S. markets may react positively in early trading.

Global

Limited to investors tracking consumer health stocks.

Counterpoint

What could challenge this read

If guidance is flat, the beat may be priced in quickly, limiting upside.

Key entities

  • Company
    Kenvue Inc.

    Consumer health products maker, ticker KVUE.

Read at source← All news

StoryKenvue posts Q3 2026 earnings amid pending Kimberly‑Clark merger

Also covered by

4 outlets

Related articles

OCT 30
$OKTAHighAI 8/10

Okta to Replace Kenvue in S&P 500 Amid Kimberly-Clark Acquisition

S&P Dow Jones Indices announced Okta (OKTA) will replace Kenvue (KVUE) in the S&P 500 on November 4, 2026, due to Kenvue's acquisition by Kimberly-Clark (KMB). Kenvue's valuation is $48.7B, with a $21.01 per-share consideration. Glaukos (GKOS) will replace Okta in the S&P MidCap 400, and McGrath RentCorp (MGRC) will replace Glaukos in the S&P SmallCap 600. Loar Holdings (LOAR) will replace LiveRamp (RAMP) in the S&P SmallCap 600 due to LiveRamp's acquisition by Publicis Groupe (PU4.DE).

securities.io3 min
OCT 30
$KVUEMedAI 8/10

Kenvue Q3 2026: Sales Up 3.2% to $3.89B, Adjusted EPS $0.29, No Guidance on Kimberly-Clark Deal

Kenvue Inc. (NYSE: KVUE) reported Q3 2026 net sales of $3.89B, up 3.2% YoY, with adjusted EPS of $0.29. Gross and operating margins improved, driven by supply-chain savings and tariff refunds. Self Care and Essential Health segments grew, while Skin Health and Beauty lagged. Free cash flow rose to $1.6B. No guidance was provided due to the pending Kimberly-Clark deal.

minichart.com.sg2 min
OCT 30
$KVUEHighAI 8/10

Kenvue posts higher profit, fourth straight sales gain in Q3 earnings

Kenvue reported Q3 adjusted earnings per share of 29 cents, up from 28 cents, and organic sales growth of 2.9%. Revenue exceeded $3.86 billion, matching analyst estimates. Self Care net sales rose 5.9%, while Skin Health and Beauty saw a slight decline. Gross and operating margins improved, and free cash flow increased. CEO Kirk Perry noted progress in operational overhaul and the pending combination with Kimberly-Clark.

qz.com2 min
OCT 30
$KVUEMed

Kenvue Delivers Fourth Consecutive Quarter of Sales Growth

Kenvue reported Q3 2026 net sales growth of 3.2% and organic sales growth of 2.9%, marking four consecutive quarters of sales growth. CEO Kirk Perry attributed the performance to strong execution, productivity initiatives, and brand investments. Skin Health & Beauty sales declined slightly, while Hair Care saw double-digit growth. Self Care segment increased by 5.9%. The company is on track for its business transformation and upcoming combination with Kimberly-Clark.

beautypackaging.com2 min
OCT 30
$KVUEHighAI 9/10

Kenvue Q3 Sales Rise 3.2% as EPS Increases 5%

Kenvue reported Q3 2026 net sales growth of 3.2% to $4.1B, with EPS up 5% to $0.22. Organic sales rose 2.9%, driven by volume growth and value realization. Gross and operating margins improved, while cash flow increased. The company did not provide guidance due to its pending merger with Kimberly-Clark.

grafa.com2 min